Executive Vice President, Strategy and Business Development
Adnan Qadir was named Chief Strategy Officer in October 2022 and leads the global Strategy & Business Development function for CSL.
In this role, Adnan is responsible for driving CSL’s enterprise strategy in service of our promise to patients. His accountabilities include enterprise strategic planning and initiatives, corporate development, business development & licensing, and alliance management.
Adnan is a global strategy leader with extensive experience across the healthcare landscape. Prior to joining CSL, Adnan served as the CSO for Surescripts, a healthcare IT company based in the U.S. where he was responsible for strategy and partnerships. He has also served as Vice President at DaVita, and Partner at Bain & Company. His work experience over 20 years spans biopharmaceuticals, payers and providers, healthcare services and healthcare technology.
Adnan holds a B.A. in Biochemistry from Columbia University and an MBA from MIT Sloan School of Management.